The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment
PHASE2
1. Study Design This is a single-center, prospective, randomized, controlle...
Status
Recruiting
Location
Clinical Research Ethics Committee of the General Hospital of Eastern Theater Command of the People's Liberation Army
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
PHASE2
The purpose of this study is to investigate the tolerability of ianalumab (...
B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies
PHASE1
This phase I trial tests safety, side effects and best dose of B-cell activ...